Articles, App Notes, Case Studies, & White Papers

51. Benefits Of Implementing EDC & Medical Coding With RTSM 3/17/2023

    Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.

52. Benefits Of Electronic Labels: Investigational Medicinal Products 12/2/2022

    When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.

53. GxP Inventory Solution Improves Clinical IP Efficiency And Compliance 8/8/2023

    Learn how this biopharmaceutical research sponsor was able to centralize and digitalize the processes involved in clinical supply production through distribution using GxP Inventory.

54. How Regional Logistics Strategy Supports Clinical Success In Europe 3/4/2026

    In an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.

55. How Long Is Your RTSM Risk Mitigation List? 11/21/2024

    While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.

56. Outsourcers Are Feeling Uneasy About Continuity Of Supply 4/14/2022

    Find out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.

57. Critical Requirements In Sourcing Comparator Drugs 8/27/2021

    Sourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.

58. IMP Labeling: EU CTR Transition Considerations 6/26/2023

    Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.

59. Vial Containment Systems For Gene And Cell Therapies 5/24/2024

    CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.

60. IRT: A New Approach To Meeting The Needs Of Early Phase Trials 8/14/2025

    As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.